Monocyte-dependent oncostatin M and TNF-α synergize to stimulate unopposed matrix metalloproteinase-1/3 secretion from human lung fibroblasts in tuberculosis

European Journal of Immunology

Volumn 38, Issue 5, 2008, Pages 1321-1330

  O'Kane, Cecilia M ^a   Elkington, Paul T ^a   Friedland, Jon S ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Human; Inflammation; Monocytes macrophages; Stromal cells

Indexed keywords

G PROTEIN COUPLED RECEPTOR; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; ONCOSTATIN M; PROSTAGLANDIN; STRESS ACTIVATED PROTEIN KINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA; BUCLADESINE; CHOLERA TOXIN; INDOMETACIN; MATRIX METALLOPROTEINASE; PERTUSSIS TOXIN;

ARTICLE; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVITY; GRANULOMA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG FIBROBLAST; MACROPHAGE; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN SECRETION; TUBERCULOSIS; WESTERN BLOTTING; ZYMOGRAPHY; CELL LINE; CULTURE MEDIUM; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; FIBROBLAST; LUNG; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHOSPHORYLATION; SECRETION; TUBERCULOMA; TUBERCULOUS PLEURISY;

BUCLADESINE; CELL LINE; CHOLERA TOXIN; CULTURE MEDIA, CONDITIONED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; HUMANS; INDOMETHACIN; LUNG; MACROPHAGES; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASES, SECRETED; MONOCYTES; ONCOSTATIN M; PERTUSSIS TOXIN; PHOSPHORYLATION; PROSTAGLANDINS; RECEPTORS, G-PROTEIN-COUPLED; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUBERCULOMA; TUBERCULOSIS, PLEURAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 47049102046     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737855     Document Type: Article

References (47)

1. Price, N. M., Farrar, J., Tran, T. T., Nguyen, T. H., Tran, T. H. and Friedland, J. S., Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo. J. Immunol. 2001. 166: 4223-4230.
2. Chang, J. C., Wysocki, A., Tchou-Wong, K. M., Moskowitz, N., Zhang, Y. and Rom, W. N., Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases. Thorax 1996. 51: 306-311.
3. Quiding-Jarbrink, M., Smith, D. A. and Bancroft, G. J., Production of matrix metalloproteinases in response to mycobacterial infection. Infect. Immun. 2001. 69: 5661-5670.
4. Visse, R. and Nagase, H., Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ. Res. 2003. 92: 827-839.
5. Brinckerhoff, C. E. and Matrisian, L. M., Matrix metalloproteinases: A tail of a frog that became a prince. Nat. Rev. Mol. Cell. Biol. 2002. 3: 207-214.
6. Price, N. M., Gilman, R. H., Uddin, J., Recavarren, S. and Friedland, J. S., Unopposed matrix metalloproteinase-9 expression in human tuberculous granuloma and the role of TNFα dependent monocyte networks. J. Immunol. 2003. 171: 5579-5586.
7. Dunsmore, S. E. and Rannels, D. E., Extracellular matrix biology in the lung. Am. J. Physiol. 1996. 270: L3-27.
8. Ohbayashi, H., Matrix metalloproteinases in lung diseases. Curr. Protein Pept. Sci. 2002. 3: 409-421.
9. Elkington, P. T. G., Emerson, J. E., Lopez-Pascua, L. D. C., O'Kane, C. M., Horncastle, D. E., Boyle, J. J. and Friedland, J. S., Mycobacterium tuberculosis up-regulates matrix metalloproteinase-1 secretion from human airway epithelial cells via a p38 MAPK switch. J. Immunol. 2005. 175: 5333-5340.
10. Elkington, P. T. G., Nuttall, R. K., Boyle, J. J., O'Kane, C. M., Horncastle, D. E., Edwards, D. R. and Friedland, J. S., Mycobacterium tuberculosis, but not vaccine BCG, specifically upregulates MATRIX metalloproteinase-1. Am. J. Respir. Crit. Care Med. 2005. 172: 1596-1604.
11. Cury, J. D., Campbell, E. J., Lazarus, C. J., Albin, R. J. and Welgus, H. G., Selective up-regulation of human alveolar macrophage collagenase production by lipopolysaccharide and comparison to collagenase production by fibroblasts. J. Immunol. 1988. 141: 4306-4312.
12. Flynn, J. L., Immunology of tuberculosis and implications in vaccine development. Tuberculosis 2004. 84: 93-101.
13. Yeager Jr, H., Azumi, N. and Underhill, C. B., Fibrosis: The formation of the granuloma matrix. In Rom, W. N. and S. M., G. (Eds.) Tuberculosis. Little, Brown and Company, New York 1996, pp 363-370.
14. Cawston, T. E., Curry, V. A., Summers, C. A., Clark, I.M., Riley, G. P., Life, P. F., Spaull, J. R. et al., The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint. Arthritis Rheum. 1998. 41: 1760-1771.
15. + T cell migration within synovial tissue. Arthritis Rheum. 2003. 48: 2472-2482.
16. Buckley, C. D., Pilling, D., Lord, J. M., Akbar, A. N., Scheel-Toellner, D. and Salmon, M., Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 2001. 22: 199-204.
17. Hui, W., Rowan, A. D., Richards, C. D. and Cawston, T. E., Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo. Arthritis Rheum 2003. 48: 3404-3418.
18. Saunders, B. M., Frank, A. A., Orme, I. M. and Cooper, A. M., Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infect. Immun. 2000. 68: 3322-3326.
19. Faffe, D. S., Flynt, L., Mellema, M., Whitehead, T. R., Bourgeois, K., Panettieri Jr, R. A., Silverman, E. S. and Shore, S. A., Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-1{beta}. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005. 288: L10400-L10408.
20. Scaffidi, A. K., Mutsaers, S. E., Moodley, Y. P., McAnulty, R. J., Laurent, G. J., Thompson, P. J. and Knight, D. A., Oncostatin M stimulates proliferation, induces collagen production and inhibits apoptosis of human lung fibroblasts. Br. J. Pharmacol. 2002. 136: 793-801.
21. Nair, B. C., DeVico, A. L., Nakamura, S., Copeland, T. D., Chen, Y., Patel, A., O'Neil, T. et al., Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science 1992. 255: 1430-1432.
22. Richards, C. D., Brown, T. J., Shoyab, M., Baumann, H. and Gauldie, J., Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro. J. Immunol. 1992. 148: 1731-1736.
23. Suda, T., Chida, K., Todate, A., Ide, K., Asada, K., Nakamura, Y., Suzuki, K. et al., Oncostatin M production by human dendritic cells in response to bacterial products. Cytokine 2002. 17: 335-340.
24. Zahrt, T. C., Molecular mechanisms regulating persistent Mycobacterium tuberculosis infection. Microbes Infect. 2003. 5: 159-167.
25. Atkinson, S., Valadas, E., Smith, S. M., Lukey, P. T. and Dockrell, H. M., Monocyte-derived macrophage cytokine responses induced by M. bovis BCG. Tubercle Lung Disease 2000. 80: 197-207.
26. Rangel Moreno, J., Estrada Garcia, I., De La Luz Garcia Hernandez, M., Aguilar Leon, D., Marquez, R. and Hernandez Pando, R., The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis. Immunology 2002. 106: 257-266.
27. Zhang, Y., Broser, M., Cohen, H., Bodkin, M., Law, K., Reibman, J. and Rom, W. N., Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J. Clin. Invest. 1995. 95: 586-592.
28. Algood, H. M., Chan, J. and Flynn, J. L., Chemokines and tuberculosis. Cytokine Growth Factor Rev. 2003. 14: 467-477.
29. Repovic, P. and Benveniste, E. N., Prostaglandin E2 is a novel inducer of oncostatin-M expression in macrophages and microglia. J. Neurosci. 2002. 22: 5334-5343.
30. Hasan, Z., Shah, B. H., Mahmood, A., Young, D. B. and Hussain, R., The effect of mycobacterial virulence and viability on MAP kinase signalling and TNF alpha production by human monocytes. Tuberculosis (Edinb) 2003. 83: 299-309.
31. Surewicz, K., Aung, H., Kanost, R. A., Jones, L., Hejal, R. and Toossi, Z., The differential interaction of p38 MAP kinase and tumor necrosis factor-alpha in human alveolar macrophages and monocytes induced by Mycobacterium tuberculois. Cell. Immunol. 2004. 228: 34-41.
32. Fietta, A. M., Morosini, M., Meloni, F., Bianco, A. M. and Pozzi, E., Pharmacological analysis of signal transduction pathways required for mycobacterium tuberculosis-induced IL-8 and MCP-1 production in human peripheral monocytes. Cytokine 2002. 19: 242-249.
33. Ameixa, C. and Friedland, J. S., Interleukin-8 secretion from Mycobacterium tuberculosis-infected monocytes is regulated by protein tyrosine kinases but not by ERK1/2 or p38 mitogen-activated protein kinases. Infect. Immun. 2002. 70: 4743-4746.
34. Humphreys, B. D., Rice, J., Kertesy, S. B. and Dubyak, G. R., Stress-activated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor. J. Biol. Chem. 2000. 275: 26792-26798.
35. Chan, E. D., Morris, K. R., Belisle, J. T., Hill, P., Remigio, L. K., Brennan, P. J. and Riches, D. W., Induction of inducible nitric oxide synthase-NO* by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-kappaB signaling pathways. Infect. Immun. 2001. 69: 2001-2010.
36. Ghayor, C., Rey, A. and Caverzasio, J., Prostaglandin-dependent activation of ERK mediates cell proliferation induced by transforming growth factor beta in mouse osteoblastic cells. Bone 2005. 36: 93-100.
37. Fujino, H., Xu, W. and Regan, J. W., Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases. J. Biol. Chem. 2003. 278: 12151-12156.
38. Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N. and Braun, M. M., Tuberculosis associated with infliximab, a tumor necrosis factor {alpha}-neutralizing agent. N. Engl. J. Med. 2001. 345: 1098-1104.
39. Ihn, H. and Tamaki, K., Oncostatin M stimulates the growth of dermal fibroblasts via a mitogen-activated protein kinase-dependent pathway. J. Immunol. 2000. 165: 2149-2155.
40. Repovic, P., Mi, K. and Benveniste, E. N., Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide. Glia 2003. 42: 433-446.
41. Davies, S. P., Reddy, H., Caivano, M. and Cohen, P., Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 2000. 351: 95-105.
42. Nemoto, O., Yamada, H., Mukaida, M. and Shimmei, M., Stimulation of TIMP-1 production by oncostatin M in human articular cartilage. Arthritis Rheum. 1996. 39: 560-566.
43. Limb, G. A., Matter, K., Murphy, G., Cambrey, A. D., Bishop, P. N., Morris, G. E. and Khaw, P. T., Matrix metalloproteinase-1 associates with intracellular organelles and confers resistance to lamin A/C degradation during apoptosis. Am. J. Pathol. 2005. 166: 1555-1563.
44. Boire, A., Covic, L., Agarwal, A., Jacques, S., Sherifi, S. and Kuliopulos, A., PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 2005. 120: 303-313.
45. McCawley, L. J. and Matrisian, L. M., Matrix metalloproteinases: they're not just for matrix anymore! Curr. Opin. Cell Biol. 2001. 13: 534-540.
46. Elkington, P. T., Green, J. A. and Friedland, J. S., Filter sterilization of highly infectious samples to prevent false negative analysis of matrix metalloproteinase activity. J. Immunol. Methods 2006. 309: 115-119.
47. Kerkvliet, E. H., Jansen, I. C., Schoenmaker, T., Beertsen, W. and Everts, V., Collagen type I, III and V differently modulate synthesis and activation of matrix metalloproteinases by cultured rabbit periosteal fibroblasts. Matrix Biol. 2003. 22: 217-227.